Investors
Contact
us
Global United States
Overview iTrack™ iTrack™ Advance Molteno3®

Advancing
clinical
outcomes and
improving
patient quality
of life

WE ARE NOVA EYE MEDICAL

With a legacy that spans more than 30 years in ophthalmology, Nova Eye Medical designs, develops, manufactures and markets a portfolio of proprietary glaucoma treatment technologies. Underpinning each of these technologies is our commitment to advance clinical outcomes and improve patient quality of life.

Learn More
Based on the principles of angioplasty, iTrack™ is an implant-free glaucoma surgery that combines 360-degree catheterization with viscodilation to mechanically remove blockages and to dilate Schlemm’s canal in order to remove outflow resistance — achieving excellent clinical outcomes while also preserving the viability of subsequent glaucoma treatments.

Learn more about
iTrack™

The Molteno3® Glaucoma Drainage Device is designed to enhance surgical utility and optimize clinical outcomes for long-term IOP control in cases of severe and complex glaucoma, with the added benefit of a simplified surgical procedure.

Learn more about
Molteno3

Latest News

See all

AGM Presentation

ASX Announcement General iTrack Molteno3 AlphaRET

23 Nov, 2023

Further Update on Proposed USA Medicare Changes

ASX Announcement General iTrack Molteno3 AlphaRET

14 Nov, 2023

6-Year Data Published in Journal of Glaucoma Demonstrates Effective, Sustained Reduction in Intraocular Pressure with iTrack™ Canaloplasty

Media Release iTrack

2 Nov, 2023

Latest Events

See all

Hawaiian Eye 2024

Grand Wailea, Maui

13 - 19 Jan, 2024

Register for updates

Caribbean Eye 2024

Cancun, Quintana Roo México

2 - 5 Feb, 2024

Register for updates

Cataract Surgery Telling It Like It Is (CSTILII)

Tampa, Florida

15 - 18 Feb, 2024

Register for updates

Advancing
clinical
outcomes and
improving
patient quality
of life

WE ARE NOVA EYE MEDICAL

With a legacy that spans more than 30 years in ophthalmology, Nova Eye Medical designs, develops, manufactures and markets a portfolio of proprietary glaucoma treatment technologies. Underpinning each of these technologies is our commitment to advance clinical outcomes and improve patient quality of life.

Learn More
Based on the principles of angioplasty, iTrack™ is an implant-free glaucoma surgery that combines 360-degree catheterization with viscodilation to mechanically remove blockages and to dilate Schlemm’s canal in order to remove outflow resistance — achieving excellent clinical outcomes while also preserving the viability of subsequent glaucoma treatments.

Learn more about
iTrack™

The Molteno3® Glaucoma Drainage Device is designed to enhance surgical utility and optimize clinical outcomes for long-term IOP control in cases of severe and complex glaucoma, with the added benefit of a simplified surgical procedure.

Learn more about
Molteno3

Latest News

See all

AGM Presentation

ASX Announcement General iTrack Molteno3 AlphaRET

23 Nov, 2023

Further Update on Proposed USA Medicare Changes

ASX Announcement General iTrack Molteno3 AlphaRET

14 Nov, 2023

6-Year Data Published in Journal of Glaucoma Demonstrates Effective, Sustained Reduction in Intraocular Pressure with iTrack™ Canaloplasty

Media Release iTrack

2 Nov, 2023

Latest Events

See all

Hawaiian Eye 2024

Grand Wailea, Maui

13 - 19 Jan, 2024

Register for updates

Caribbean Eye 2024

Cancun, Quintana Roo México

2 - 5 Feb, 2024

Register for updates

Cataract Surgery Telling It Like It Is (CSTILII)

Tampa, Florida

15 - 18 Feb, 2024

Register for updates
This website uses cookies to ensure you get the best experience on our website.
The cookies do not store any personalised information. Learn More